Company Overview and News


Add FAE
to your dashboard

Headline News

Week In Review: Management Offers $3.5 Billion To Privatize Mindray Medical

2016-09-18 seekingalpha
Mindray Medical (NYSE:MR), the Shenzhen medical device maker, received a going-private offer from its three top executives at $30 per ADS, a modest 10% over the previous day's closing price. The offer values Mindray at $3.5 billion. In its Q1 earnings report, Mindray warned that its net income for 2015 would fall by a mid-teens percentage. Brokerage houses responded by lowering their ratings on the company, some to a sell and others to a strong sell.

Aralez Pharmaceuticals Inc.: Upcoming Catalysts Create Tremendous Upside

2016-08-18 seekingalpha
Aralez's drug Yosprala is highly likely to obtain FDA approval on or before its September 14, 2016 PDUFA date. Anticipated Q4 launch in USA with 110 sales reps.

Tribute Announces Results of Shareholder Vote

2016-02-01 marketwired
MILTON, ONTARIO--(Marketwired - Feb. 1, 2016) - Tribute Pharmaceuticals Canada Inc. (TSX VENTURE:TRX)(OTCQX:TBUFF) ("Tribute" or the "Company"), a specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada and the U.S., today announced that it has received overwhelming shareholder approval of...

Leading Independent Advisors Recommend That Tribute Shareholders Vote FOR the Transaction

2016-01-21 marketwired
MILTON, ONTARIO--(Marketwired - Jan. 21, 2016) - Tribute Pharmaceuticals Canada Inc. (TSX VENTURE:TRX)(OTCQX:TBUFF) ("Tribute" or the "Company"), a specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada and the U.S., is pleased to announce that Institutional Shareholder Services ("ISS") and...